---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-239559"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2026-05-26T20:54:31+00:00"
generated_at: "2026-05-26T20:57:22.086453+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics stockholders elect three Class II directors, ratify KPMG, approve say-on-pay

## Summary
- Michael M. Morrisey elected with 45.3M For, 13.8M Withheld; Patrick G. Enright with 54.7M For; James R. Meyers with 58.9M For.
- Ratification of KPMG as auditor for FY 2026 approved (61.8M For, 44.7K Against, 87.3K Abstain).
- Advisory vote on executive compensation approved (56.6M For, 2.4M Against, 84.3K Abstain, 2.9M Broker non-votes).
- 71.7M shares outstanding and entitled to vote as of record date March 24, 2026.

## SEC filing metadata
- accession: 0001193125-26-239559
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2026-05-26T20:54:31+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/0001193125-26-239559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/vera-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-239559
- JSON: https://secwatch.observer/filing/0001193125-26-239559.json
- Plain text: https://secwatch.observer/filing/0001193125-26-239559.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.